Mozessohn, Lee, and Rena Buckstein. 2020. “Should We Move past Erythropoietin-Stimulating Agent Monotherapy in Lower-Risk Myelodysplastic Syndromes?”. Haematologica, September. Pavia, Italy. https://doi.org/10.3324/haematol.2025.288157.